Nayak, NehaVaidya, Sapna AmatyaVaidya, Karishma Malla2025-12-312025-12-312024https://hdl.handle.net/20.500.14572/3962Neha Nayak Department of Obstetrics and Gynecology, Paropakar Maternity and Women’s Hospital. Sapna Amatya Vaidya Department of Obstetrics and Gynecology, Paropakar Maternity and Women’s Hospital. Karishma Malla Vaidya Department of Pathology,Paropakar Maternity and Women’s Hospital.Abstract: Introduction: Cervical cancer is considered to be an international health issue as there is a high incidence in many LMICs. The rate of cervical cancer in the Nepal is 16.4 per 100,000 women. Special mention should be made of its applicability in determining the presence of cervical precancerous lesions, hence the choice of colposcopy as a significant guide to cervical biopsy. This paper seeks to establish the relationship between colposcopic grading of cervix with Swede score and histological examinations of cervical punch biopsy. Methods: This cross-sectional study was carried out on 81 women attending the Department of Gynaecology of tertiary care teaching hospital Paropakar Maternity and Women’s Hospital, Kathmandu. All the women with either abnormal cervical cytology result or HPV positive status were subjected to colposcopic guided biopsy using Swede score. Histopathology was then compared to the findings seen on colposcopy. Results: 54%(n=44) had abnormal biopsy reports.58% had Swede score>=5. Swede score>= 5 had sensitivity, specificicity, NPV and PPV of 81.2%, 70.2%, 76.5% and 76% respectively.Swede score>= 8 had sensitivity, specificicity, NPV and PPV of 25.5%, 97%, 91.6% and 53.6% respectively Conclusion: Colposcopy, using Swede score>=5 as cut off is sensitive in screening of cervix and can be used as a basis for treating patients directly as a “see and treat” method. Keywords: Cervical cancer, Colposcopy, Screening, Swede scoreen-USCervical cancerColposcopyScreeningSwede scoreArticle